Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Language
Publication year range
1.
Gastroenterology ; 142(4): 967-977.e2, 2012 Apr.
Article in English | MEDLINE | ID: mdl-22245843

ABSTRACT

BACKGROUND & AIMS: Notch signaling mediates embryonic vascular development and normal vascular remodeling; Notch1 knockout mice develop nodular regenerative hyperplasia (NRH). The pathogenesis of NRH is unclear, but has been associated with vascular injury in the liver sinusoids in clinical studies. We investigated the role of Notch1 signaling in liver sinusoidal endothelial cells (LSECs). METHODS: We studied MxCre Notch1(lox/lox) mice (conditional knockout mice without tissue-specific disruption of Notch1); mice with hepatocyte-specific knockout were created by crossing Notch1(lox/lox) with AlbCre(+/-) mice. Portal vein pressure was measured; morphology of the hepatic vasculature was assessed by histologic and scanning electron microscopy analyses. We performed functional and expression analyses of isolated liver cells. RESULTS: MxCre-induced knockout of Notch1 led to NRH, in the absence of fibrosis, with a persistent increase in proliferation of LSECs. Notch1 deletion led to de-differentiation, vascular remodeling of the hepatic sinusoidal microvasculature, intussusceptive angiogenesis, and dysregulation of ephrinB2/EphB4 and endothelial tyrosine kinase. Time-course experiments revealed that vascular changes preceded node transformation. MxCre Notch1(lox/lox) mice had reduced endothelial fenestrae and developed portal hypertension and hepatic angiosarcoma over time. In contrast, mice with hepatocyte-specific disruption of Notch1 had a normal phenotype. CONCLUSIONS: Notch1 signaling is required for vascular homeostasis of hepatic sinusoids; it maintains quiescence and differentiation of LSECs in adult mice. Disruption of Notch1 signaling in LSECs leads to spontaneous formation of angiosarcoma, indicating its role as a tumor suppressor in the liver endothelium.


Subject(s)
Cell Transformation, Neoplastic/metabolism , Endothelial Cells/metabolism , Focal Nodular Hyperplasia/metabolism , Hemangiosarcoma/metabolism , Liver Neoplasms/metabolism , Liver/blood supply , Neovascularization, Pathologic/metabolism , Receptor, Notch1/metabolism , Animals , Cell Dedifferentiation , Cell Proliferation , Cell Transformation, Neoplastic/genetics , Cell Transformation, Neoplastic/pathology , Cells, Cultured , Endothelial Cells/pathology , Ephrin-B2/metabolism , Focal Nodular Hyperplasia/genetics , Focal Nodular Hyperplasia/pathology , Genotype , Hemangiosarcoma/genetics , Hemangiosarcoma/pathology , Hepatocytes/metabolism , Hepatocytes/pathology , Humans , Hypertension, Portal/genetics , Hypertension, Portal/metabolism , Hypertension, Portal/physiopathology , Liver/metabolism , Liver/pathology , Liver Neoplasms/genetics , Liver Neoplasms/pathology , Mice , Mice, Inbred C57BL , Mice, Knockout , Microscopy, Electron, Scanning , Neovascularization, Pathologic/genetics , Neovascularization, Pathologic/pathology , Phenotype , Portal Pressure , Receptor, EphB4/metabolism , Receptor, Notch1/deficiency , Receptor, Notch1/genetics , Signal Transduction , Time Factors
2.
J Proteomics ; 74(5): 672-82, 2011 May 01.
Article in English | MEDLINE | ID: mdl-21338724

ABSTRACT

Dahl salt-sensitive (DS) and salt-resistant (DR) inbred rat strains represent a well established animal model for cardiovascular research. Upon prolonged administration of high-salt-containing diet, DS rats develop systemic hypertension, and as a consequence they develop left ventricular hypertrophy, followed by heart failure. The aim of this work was to explore whether this animal model is suitable to identify biomarkers that characterize defined stages of cardiac pathophysiological conditions. The work had to be performed in two stages: in the first part proteomic differences that are attributable to the two separate rat lines (DS and DR) had to be established, and in the second part the process of development of heart failure due to feeding the rats with high-salt-containing diet has to be monitored. This work describes the results of the first stage, with the outcome of protein expression profiles of left ventricular tissues of DS and DR rats kept under low salt diet. Substantial extent of quantitative and qualitative expression differences between both strains of Dahl rats in heart tissue was detected. Using Principal Component Analysis, Linear Discriminant Analysis and other statistical means we have established sets of differentially expressed proteins, candidates for further molecular analysis of the heart failure mechanisms.


Subject(s)
Gene Expression Regulation , Heart Failure/metabolism , Heart Ventricles/metabolism , Muscle Proteins/biosynthesis , Proteome/biosynthesis , Animals , Disease Models, Animal , Heart Failure/chemically induced , Heart Failure/pathology , Heart Failure/physiopathology , Heart Ventricles/pathology , Heart Ventricles/physiopathology , Proteomics/methods , Rats , Rats, Inbred Dahl , Sodium Chloride, Dietary/adverse effects , Sodium Chloride, Dietary/pharmacology
3.
Eur J Heart Fail ; 12(8): 797-804, 2010 Aug.
Article in English | MEDLINE | ID: mdl-20388649

ABSTRACT

AIMS: To test acute effects of the corticotropin-releasing factor-related peptide urocortin 2 (Ucn2) on left ventricular (LV) function and the propensity for ventricular arrhythmias in the isolated heart of an animal model of hypertension-induced heart failure. METHODS AND RESULTS: Hearts from Dahl salt-sensitive rats with severe LV dysfunction were perfused according to Langendorff. Left ventricular developed pressure and the positive and negative derivatives of LV pressure were analysed before and after perfusion with Ucn2 (n = 15) or normal perfusion solution (control, n = 9). Intracellular calcium cycling parameters were assessed by surface fluorometry. Furthermore, monophasic action potential duration (MAPD) and ventricular fibrillation threshold (VFT) were determined, the latter by a train-of-pulses method at increasing voltage to scan the vulnerable period of repolarization. Urocortin 2 significantly affected intracellular calcium cycling and improved LV contractile function and relaxation. Compared with baseline values, Ucn2 significantly decreased MAPD at 30, 50, and 90% repolarization and significantly increased VFT compared with baseline values. No changes were observed in control experiments. CONCLUSION: Administration of Ucn2 rapidly improves LV function and increases VF threshold in failing, isolated rat hearts with increased propensity for ventricular arrhythmias. These observations suggest a potential use of Ucn2 as a safe and novel agent for the treatment of acute heart failure.


Subject(s)
Arrhythmias, Cardiac/physiopathology , Heart Failure/physiopathology , Hypertrophy, Left Ventricular/physiopathology , Myocardium/pathology , Urocortins/pharmacology , Acute Disease , Animals , Disease Models, Animal , Fluorometry , Heart Failure/diagnostic imaging , Hemodynamics , Hypertrophy, Left Ventricular/diagnostic imaging , Intracellular Calcium-Sensing Proteins , Male , Perfusion , Rats , Rats, Inbred Dahl , Sodium, Dietary , Ultrasonography , Urocortins/analysis , Urocortins/therapeutic use , Ventricular Dysfunction, Left/physiopathology , Ventricular Fibrillation/diagnostic imaging , Ventricular Fibrillation/physiopathology
4.
Hypertension ; 53(4): 739-44, 2009 Apr.
Article in English | MEDLINE | ID: mdl-19204182

ABSTRACT

Recently, novel corticotropin-releasing factor-related peptides, named urocortin 1, 2, and 3, and a distinct cardiac and peripheral vascular receptor (corticotropin-releasing factor receptor 2) were described being part of a peripheral corticotropin-releasing factor system modulating cardiovascular function in response to stress. Vasorelaxation and blood pressure lowering have been reported after acute administration of these peptides. No data are available on the acute and chronic effects of urocortin 2 on blood pressure in models of arterial hypertension. To test these effects, hypertensive salt-sensitive and normotensive salt-resistant Dahl rats were randomly assigned to twice-daily applications of urocortin 2 or vehicle for 5 weeks. Blood pressure, heart rate, and left ventricular dimension and function were recorded at baseline, after initial application, and, together with cardiac and aortic expression of urocortin 2 and its receptor, after 5 weeks of treatment. Urocortin 2 significantly reduced blood pressure in hypertensive rats without affecting heart rate. Long-term urocortin 2 treatment in hypertensive rats induced sustained blood pressure reduction and diminished the development of hypertension-induced left ventricular hypertrophy and the deterioration of left ventricular contractile function. Corticotropin-releasing factor receptor 2 expression was preserved despite chronic stimulation by urocortin 2. In conclusion, our study shows that, in an animal model of arterial hypertension, urocortin 2 has immediate and sustained blood pressure-lowering effects. Beneficial effects on blood pressure, left ventricular dimension, and function, together with preserved receptor expression, suggest that corticotropin-releasing factor receptor 2 stimulation by urocortin 2 may represent a novel approach to the treatment of arterial hypertension.


Subject(s)
Antihypertensive Agents/pharmacology , Blood Pressure/drug effects , Corticotropin-Releasing Hormone/pharmacology , Hypertension/drug therapy , Hypertension/metabolism , Urocortins/pharmacology , Animals , Corticotropin-Releasing Hormone/genetics , Disease Models, Animal , Echocardiography , Gene Expression/drug effects , Heart Rate/drug effects , Hypertrophy, Left Ventricular/diagnostic imaging , Hypertrophy, Left Ventricular/drug therapy , Hypertrophy, Left Ventricular/metabolism , Male , Rats , Rats, Inbred Dahl , Receptors, Corticotropin-Releasing Hormone/genetics , Urocortins/genetics
5.
Eur J Pharmacol ; 586(1-3): 251-8, 2008 May 31.
Article in English | MEDLINE | ID: mdl-18405893

ABSTRACT

Persistent Nuclear Factor-kappaB (NF-kappaB) activation is hypothesized to contribute to myocardial injuries following ischemia-reperfusion. Because inhibition or control of NF-kappaB signaling in the heart probably confers cardioprotection, we determined the potency of the NF-kappaB inhibitor dimethyl fumarate (DMF) in cardiovascular cells, and determined whether administration of DMF translates into beneficial effects in an animal model of myocardial infarction. In rat heart endothelial cells (RHEC), we analysed inhibitory effects of DMF on NF-kappaB using shift assay and immunohistofluorescence. In in vivo experiments, male Sprague Dawley rats undergoing left coronary artery occlusion for 45 min received either DMF (10 mg/kg body weight) or vehicle 90 min before ischemia as well as immediately before ischemia. After 120 min of reperfusion, the hearts were stained with phthalocyanine blue dye and triphenyltetrazolium chloride. Additionally, acute hemodynamic and electrophysiologic effects of DMF were determined in dose-response experiments in isolated perfused rat hearts. DMF inhibited TNF-alpha-induced nuclear entry of NF-kappaB in RHEC. In in vivo experiments, myocardial infarct size was significantly smaller in rats that had received DMF (20.7%+/-9.7% in % of risk area; n=17) than in control rats (28.2%+/-6.2%; n=15). Dose-response experiments in isolated perfused rat hearts excluded acute hemodynamic or electrophysiologic effects as mechanisms for the effects of DMF. DMF inhibits nuclear entry of NF-kappaB in RHEC and reduces myocardial infarct size after ischemia and reperfusion in rats in vivo. There was no indication that the beneficial effects of DMF were due to acute hemodynamic or electrophysiologic influences.


Subject(s)
Dermatologic Agents/therapeutic use , Fumarates/therapeutic use , Myocardial Infarction/drug therapy , Myocardial Infarction/pathology , NF-kappa B/antagonists & inhibitors , Psoriasis/drug therapy , Animals , Dimethyl Fumarate , Electrocardiography/drug effects , Electrophoretic Mobility Shift Assay , Electrophysiology , Endothelial Cells/drug effects , Endothelial Cells/pathology , Fluorescent Antibody Technique , Heart Rate/drug effects , In Vitro Techniques , Male , Myocardial Reperfusion Injury/pathology , Myocardium/cytology , Myocardium/pathology , Nuclear Proteins/metabolism , Rats , Rats, Sprague-Dawley
6.
J Proteome Res ; 7(12): 5211-20, 2008 Dec.
Article in English | MEDLINE | ID: mdl-19367704

ABSTRACT

Methodological evaluation of the proteomic analysis of cardiovascular-tissue material has been performed with a special emphasis on establishing examinations that allow reliable quantitative analysis of silver-stained readouts. Reliability, reproducibility, robustness and linearity were addressed and clarified. In addition, several types of normalization procedures were evaluated and new approaches are proposed. It has been found that the silver-stained readout offers a convenient approach for quantitation if a linear range for gel loading is defined. In addition, a broad range of a 10-fold input (loading 20-200 microg per gel) fulfills the linearity criteria, although at the lowest input (20 microg) a portion of protein species will remain undetected. The method is reliable and reproducible within a range of 65-200 microg input. The normalization procedure using the sum of all spot intensities from a silver-stained 2D pattern has been shown to be less reliable than other approaches, namely, normalization through median or through involvement of interquartile range. A special refinement of the normalization through virtual segmentation of pattern, and calculation of normalization factor for each stratum provides highly satisfactory results. The presented results not only provide evidence for the usefulness of silver-stained gels for quantitative evaluation, but they are directly applicable to the research endeavor of monitoring alterations in cardiovascular pathophysiology.


Subject(s)
Cardiovascular Diseases/metabolism , Cardiovascular System/metabolism , Gene Expression Regulation , Heart/physiology , Myocardium/metabolism , Proteome , Proteomics/methods , Animals , Electrophoresis, Gel, Two-Dimensional , Gene Expression Profiling , Humans , Image Processing, Computer-Assisted , Rats , Rats, Inbred Dahl , Rats, Wistar , Species Specificity
SELECTION OF CITATIONS
SEARCH DETAIL